Skip to main content

NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.

Publication ,  Journal Article
Pallera, A; Altman, JK; Berman, E; Abboud, CN; Bhatnagar, B; Curtin, P; DeAngelo, DJ; Gotlib, J; Hagelstrom, RT; Hobbs, G; Jagasia, M ...
Published in: J Natl Compr Canc Netw
December 2016

The NCCN Guidelines for Chronic Myeloid Leukemia (CML) provide recommendations for the management of chronic-phase and advanced-phase CML in adult patients. The median age of disease onset is 67 years. However, because CML occurs in all age groups, clinical care teams should be prepared to address issues relating to fertility and pregnancy with patients who are of reproductive age at the time of diagnosis. CML is relatively rare in children and there are no evidence-based recommendations for the management of CML in pediatric population. These NCCN Guidelines Insights discuss special considerations for the management of CML during pregnancy and for the management of CML in the pediatric population.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

December 2016

Volume

14

Issue

12

Start / End Page

1505 / 1512

Location

United States

Related Subject Headings

  • Withholding Treatment
  • Protein Kinase Inhibitors
  • Prognosis
  • Pregnancy Complications, Neoplastic
  • Pregnancy
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Leukemia, Myeloid, Chronic-Phase
  • Humans
  • Fertility
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pallera, A., Altman, J. K., Berman, E., Abboud, C. N., Bhatnagar, B., Curtin, P., … Radich, J. P. (2016). NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017. J Natl Compr Canc Netw, 14(12), 1505–1512. https://doi.org/10.6004/jnccn.2016.0162
Pallera, Arnel, Jessica K. Altman, Ellin Berman, Camille N. Abboud, Bhavana Bhatnagar, Peter Curtin, Daniel J. DeAngelo, et al. “NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.J Natl Compr Canc Netw 14, no. 12 (December 2016): 1505–12. https://doi.org/10.6004/jnccn.2016.0162.
Pallera A, Altman JK, Berman E, Abboud CN, Bhatnagar B, Curtin P, et al. NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017. J Natl Compr Canc Netw. 2016 Dec;14(12):1505–12.
Pallera, Arnel, et al. “NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.J Natl Compr Canc Netw, vol. 14, no. 12, Dec. 2016, pp. 1505–12. Pubmed, doi:10.6004/jnccn.2016.0162.
Pallera A, Altman JK, Berman E, Abboud CN, Bhatnagar B, Curtin P, DeAngelo DJ, Gotlib J, Hagelstrom RT, Hobbs G, Jagasia M, Kantarjian HM, Kropf P, Metheny L, Moore JO, Ontiveros E, Purev E, Quiery A, Reddy VVB, Rose MG, Shah NP, Smith BD, Snyder DS, Sweet KL, Tibes R, Yang DT, Gregory K, Sundar H, Deininger M, Radich JP. NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017. J Natl Compr Canc Netw. 2016 Dec;14(12):1505–1512.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

December 2016

Volume

14

Issue

12

Start / End Page

1505 / 1512

Location

United States

Related Subject Headings

  • Withholding Treatment
  • Protein Kinase Inhibitors
  • Prognosis
  • Pregnancy Complications, Neoplastic
  • Pregnancy
  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Leukemia, Myeloid, Chronic-Phase
  • Humans
  • Fertility